Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2019
Apr. 30, 2018
Cash flows from operating activities:    
Net loss $ (10,849) $ (5,471)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 550 787
Provision for bad debts 98  
Stock-based compensation (credit) expense (434) 879
Deferred income taxes 368  
Unrealized foreign currency transaction gain 1,207 575
Other 42 (7)
Changes in operating assets and liabilities, including impact of acquisitions:    
Accounts receivable 9,870 10,449
Unbilled receivables (491) (3,571)
Inventory 166 (80)
Prepaid expenses and other current assets and other assets (355) 224
Accounts payable (1,591) (576)
Accrued expenses and other liabilities (438) (6,139)
Deferred revenue (828) (2,778)
Other operating activities   2,356
Net cash used in operating activities (2,685) (3,352)
Cash flows from investing activities:    
Purchases of property, plant and equipment (50) (113)
Cash paid for acquisitions, net (3,838)  
Purchases of marketable securities (6,231) (3,830)
Proceeds from sales and maturities of marketable securities 6,946 2,009
Net cash used in investing activities (3,173) (1,934)
Cash flows from financing activities:    
Proceeds from issuance of common stock 9 37
Other financing activities   (9)
Net cash provided by financing activities 9 28
Effect of exchange rate on cash and cash equivalents 229 453
Net decrease in cash and cash equivalents (5,620) (4,805)
Cash and cash equivalents at beginning of period 20,317 43,661
Cash and cash equivalents at end of period 14,697 38,856
Supplemental disclosure of cash flow information    
Income taxes paid 17 $ 182
Non-cash activities:    
Purchases of property and equipment included in accounts payable 19  
Fair value of common stock issued in acquisition $ 874